Display options
Share it on

Oncol Lett. 2017 Mar;13(3):1083-1086. doi: 10.3892/ol.2017.5599. Epub 2017 Jan 12.

Paraganglioma of the organ of Zuckerkandl associated with a somatic .

Oncology letters

Ahmad Esmaeel Abdullah, Carole Guerin, Alessio Imperiale, Anne Barlier, Stéphanie Battini, Morgane Pertuit, Philippe Roche, Wassim Essamet, Bernard Vaisse, Karel Pacak, Fréderic Sebag, David Taïeb

Affiliations

  1. Department of Nuclear Medicine, La Timone University Hospital, European Center for Research in Medical Imaging, Aix-Marseille University, 13385 Marseille Cedex 5, France.
  2. Department of Endocrine Surgery, Conception Hospital, Aix-Marseille University, 13005 Marseille, France.
  3. Department of Biophysics and Nuclear Medicine, Hautepierre Hospital, University Hospitals of Strasbourg, 67200 Strasbourg, France.
  4. ICube Joint Research Unit 7357, University of Strasbourg/French National Center for Scientific Research and Federation of Translational Medicine of Strasbourg, Faculty of Medicine, 67085 Strasbourg, France.
  5. Laboratory of Biochemistry and Molecular Biology, Conception Hospital, Aix-Marseille University, 13005 Marseille, France.
  6. Integrative Structural and Chemical Biology and Interaction Dynamics and Drug Design Platform, Cancer Research Centre of Marseille, Institut Paoli Calmettes, 13273 Marseille, France.
  7. Department of Neuropathology, La Timone University Hospital, Aix-Marseille University, 13385 Marseille Cedex 5, France.
  8. Department of Hypertension, La Timone University Hospital, Aix-Marseille University, 13385 Marseille Cedex 5, France.
  9. Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
  10. Cancer Research Centre of Marseille Affiliated to Inserm (UMR1068), Institut Paoli-Calmettes, 13273 Marseille, France.

PMID: 28454217 PMCID: PMC5403169 DOI: 10.3892/ol.2017.5599

Abstract

Paragangliomas of the organ of Zuckerkandl (OZ-PGL) are rare tumors that, in >70% of cases, occur in association with succinate dehydrogenase complex iron sulfur subunit B (

Keywords: endothelial PAS domain-containing protein 1; nuclear magnetic resonance spectroscopy; paraganglioma

References

  1. PLoS One. 2013 Nov 27;8(11):e80539 - PubMed
  2. Endocr Relat Cancer. 2010 Jun 03;17(3):581-8 - PubMed
  3. J Clin Endocrinol Metab. 2013 May;98(5):E908-13 - PubMed
  4. N Engl J Med. 2008 Jan 10;358(2):162-8 - PubMed
  5. Curr Probl Cancer. 2014 Jan-Feb;38(1):7-41 - PubMed
  6. J Neuroendocrinol. 2013 Jan;25(1):34-47 - PubMed
  7. Clin Sci. 1953 Nov;12(4):317-25 - PubMed
  8. Endocr Relat Cancer. 2014 Jun;21(3):495-504 - PubMed
  9. Am J Surg. 2006 Aug;192(2):224-34 - PubMed
  10. N Engl J Med. 2012 Nov 29;367(22):2161; author reply 2161-2 - PubMed
  11. Hum Mol Genet. 2013 Jun 1;22(11):2169-76 - PubMed
  12. N Engl J Med. 2012 Sep 6;367(10):922-30 - PubMed
  13. J Clin Endocrinol Metab. 2011 Mar;96(3):717-25 - PubMed
  14. Neurochem Res. 2005 Jun-Jul;30(6-7):921-5 - PubMed
  15. Blood. 2013 Mar 28;121(13):2563-6 - PubMed
  16. J Clin Oncol. 2013 May 1;31(13):1690-8 - PubMed
  17. Ophthalmology. 2014 Nov;121(11):2291-3 - PubMed
  18. Nat Rev Cancer. 2011 Dec 15;12(1):9-22 - PubMed

Publication Types